Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes

Open access
Martinet, Ludovic, Le Guellec, Sophie, Filleron, Thomas, Lamant, Laurence, Meyer, Nicolas, Rochaix, Philippe, Garrido, Ignacio, Girard, Jean-Philippe·2012·OncoImmunology

Abstract

The presence of tumor-infiltrating lymphocytes (TILs) is a strong prognostic parameter for local dissemination and overall survival in melanoma. Lymphocyte migration from blood into peripheral tissues is mainly regulated by vascular endothelium. However, the blood vessels and mechanisms governing the recruitment of TILs in melanoma tumors remain poorly understood. Here, we show that high endothelial venules (HEVs), specialized blood vessels for lymphocyte extravasation into lymphoid tissues, are frequently found in melanoma tumors and are associated with high levels of lymphocyte infiltration. The analysis of 225 primary melanomas revealed that lymphocytes specifically infiltrated HEV-rich areas of melanoma tumors and that the density of MECA-79+ HEVs was variable among patients and strongly correlated with CD3+, CD8+ and CD20+ TIL densities. Inflammatory (CCL5, CXCL9, CXCL10 and CXCL11) and lymphoid (CCL21, CCL19 and CXCL13) chemokines as well as TH1 and naïve T-cell genes were overexpressed in melanoma samples with high densities of tumor HEVs. Mature dendritic cells (mDCs) were frequently found around tumor HEVs and densities of HEVs and DC-LAMP+ mDCs within tumor stroma were strongly correlated. DCs which maintain HEVs in lymph nodes, may thus also contribute to the regulation of HEVs in melanomas. Finally, we found significantly higher densities of tumor HEVs in melanomas with tumor regression, low Clark level of invasion and thin Breslow thickness (all p < 0.001). The strong association between tumor HEVs, TILs, mDCs and clinical parameters of melanoma, supports a critical role for HEVs in limiting malignant melanoma development through both naïve and effector T-lymphocyte recruitment and activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/onci.20492

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 35

  1. 10.1200/JCO.2009.27.2146 · DOI · Paper page
  2. 10.1126/science.1129139 · DOI · Paper page
  3. 10.1158/0008-5472.CAN-11-1316 · DOI · Paper page
  4. 10.1200/JCO.2006.08.9755 · DOI · Paper page
  5. 10.1093/jnci/81.24.1893 · DOI · Paper page
  6. 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5 · DOI · Paper page
  7. 10.1200/JCO.2005.00.240 · DOI · Paper page
  8. 10.1200/JCO.2005.05.2498 · DOI · Paper page
  9. 10.1200/JCO.2006.10.2822 · DOI
  10. 10.1007/s00262-011-1026-2 · DOI
  11. 10.1016/0167-5699(95)80023-9 · DOI · Paper page
  12. 10.1038/nm1699 · DOI · Paper page
  13. 10.1158/1078-0432.CCR-06-2450 · DOI
  14. 10.1038/nri1222 · DOI · Paper page
  15. 10.1038/nri1786 · DOI · Paper page
  16. 10.1073/pnas.0407503101 · DOI
  17. 10.1158/0008-5472.CAN-11-0431 · DOI · Paper page
  18. 10.1200/JCO.2009.23.4799 · DOI · Paper page
  19. 10.1016/S1470-2045(11)70155-3 · DOI · Paper page
  20. 10.1038/nature10540 · DOI · Paper page
  21. Oble DA, 2009, Cancer Immun, 9, 3
  22. 10.1146/annurev-immunol-031210-101324 · DOI · Paper page
  23. 10.1111/1523-1747.ep12292705 · DOI
  24. Wagner SN, 1998, Lab Invest, 78, 541
  25. 10.1038/nri1806 · DOI · Paper page
  26. 10.1200/JCO.2006.05.9584 · DOI · Paper page
  27. 10.1158/0008-5472.CAN-11-0952 · DOI · Paper page
  28. 10.1084/jem.20092454 · DOI · Paper page
  29. 10.1016/S1074-7613(01)00094-2 · DOI · Paper page
  30. 10.1038/ni1029 · DOI · Paper page
  31. 10.4049/jimmunol.179.3.1960 · DOI
  32. 10.1016/S1074-7613(02)00480-6 · DOI · Paper page
  33. 10.1172/JCI17656 · DOI
  34. 10.1038/nrclinonc.2009.42 · DOI
  35. 10.1007/s00262-003-0425-4 · DOI

Cited by

See all 193

Metadata

Authors
Martinet, L., Le Guellec, S., Filleron, T., Lamant, L., Meyer, N., Rochaix, P., Garrido, I., & Girard, J.-P.
Venue
OncoImmunology
Published
2012-09
Volume
1
Issue
6
Pages
829-839
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W1538257125
Cited by
193
References
6
FWCI
4.40
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes. https://app.cochat.ai/papers/10.4161/onci.20492
The paper
Martinet, L., Le Guellec, S., Filleron, T., Lamant, L., Meyer, N., Rochaix, P., Garrido, I., & Girard, J.-P. (2012). High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes. OncoImmunology. https://doi.org/10.4161/onci.20492

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.